$DMAC 4 SEC Filings

Filed On	Filing
12 Aug 2026	Form 4: Pauls Dietrich John, Director Received 60,200 shares as a grant or award
03 Jun 2026	Form 4: Giuffre Randall Michael, Director Granted 40,412 Stock Option (right to buy)
03 Jun 2026	Form 4: Kuntz Richard, Director Granted 40,412 Stock Option (right to buy)
03 Jun 2026	Form 4: O'Connor Daniel J., Director Granted 40,412 Stock Option (right to buy)
03 Jun 2026	Form 4: Lewis Tanya, Director Granted 40,412 Stock Option (right to buy)
03 Jun 2026	Form 4: Semba Charles Pauling, Director Granted 40,412 Stock Option (right to buy)
03 Jun 2026	Form 4: Parsons James T., Director Granted 51,189 Stock Option (right to buy)
03 Jun 2026	Form 4: Pauls Dietrich John, Director Granted 380,000 Stock Option (right to buy)
03 Jun 2026	Form 4: Kellen Scott, CFO & Secretary Granted 162,000 Stock Option (right to buy)
03 Jun 2026	Form 4: Krop Julie, Chief Medical Officer Granted 67,500 Stock Option (right to buy)
06 Jan 2026	Form 4: Parsons James T., Director Received 10,095 shares as a grant or award ($85K)
06 Jan 2026	Form 4: Giuffre Randall Michael, Director Received 6,175 shares as a grant or award ($52K)
06 Jan 2026	Form 4: Semba Charles Pauling, Director Received 3,355 shares as a grant or award ($28.2K)
08 Dec 2025	Form 4: Stahlberg Jan, 10% owner and 1 other Bought 187,393 shares ($1.22M) · Bought 182,882 shares ($1.23M) · Bought 240,352 shares ($1.73M) · 4 more
25 Nov 2025	Form 4: Parsons James T., Director Received 12,000 shares by exercise or conversion ($26.4K)
03 Nov 2025	Form 4: Krop Julie, Chief Marketing Officer Granted 450,000 Stock Option (right to buy)
04 Sep 2025	Form 4: Stahlberg Jan, 10% owner and 1 other Bought 293,601 shares ($1.73M) · Bought 70,414 shares ($422K) · Bought 8,233 shares ($49.4K) · 6 more
25 Jul 2025	Form 4: Stahlberg Jan, 10% owner and 1 other Bought 1,542,857 shares ($5.4M)
25 Jul 2025	Form 4: Von Koch Thomas, 10% owner and 2 others Bought 2,857,142 shares ($10M)
25 Jul 2025	Form 4: Jacinto Richard Ii, 10% owner Bought 400,000 shares ($1.4M)

Comments